Asterias Biotherapeutic: Spinal Injury Stem Cell Therapy Play – Seeking Alpha
|
Asterias Biotherapeutic: Spinal Injury Stem Cell Therapy Play
Seeking Alpha There is currently no FDA approved treatment for Spinal Cord Injury, which is estimated to have about 17,700 new cases each year in the US alone. Asterias Biotherapeutic, a US small cap biotech company, is developing a stem cell therapy for SCI and has … |
